| Dr Yvette Simon Goldfine, MD | |
|
500 N Bridge St, Bridgewater, NJ 08807-2135 | |
| (908) 253-3122 | |
| (908) 704-1790 |
| Full Name | Dr Yvette Simon Goldfine |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 500 N Bridge St, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508949900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MA33846 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yvette Simon Goldfine, MD 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 253-3122 | Dr Yvette Simon Goldfine, MD 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 253-3122 |
News Archive
Researchers using functional MRI (fMRI) have determined that the circuitry in the area of the brain responsible for suppressing memory is dysfunctional in patients suffering from stress-related psychiatric disorders.
Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.
In new findings that could have an impact the development of therapies for a number of currently untreatable brain disorders such as Parkinson's and Huntington's diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found, for the first time, that a specific signaling circuit in the brain is deeply involved in motor activity.
LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, today announced results from a clinical study demonstrating that patients with normal levels of lipoprotein(a) may retain significant risk of atherosclerosis due to an elevated low density lipoprotein particle (LDL-P) number.
Baylor Research Institute has been awarded a patent from the U.S. Patent Office for a potential strategy to improve the outcomes of islet cell transplantation for patients with type 1 diabetes and chronic pancreatitis.
› Verified 3 days ago
Dr. Laura Owens Bakey, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Dr. Justin Joseph Lo Re, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1125 Route 22 Ste 155, Bridgewater, NJ 08807 Phone: 732-667-1123 Fax: 732-560-3206 | |
Dr. Marcella S Bernson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Henry Odunlami, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 380 Foothill Rd Ste 1, Bridgewater, NJ 08807 Phone: 908-231-0511 Fax: 908-231-1115 | |
Dr. Tasneem Shaikh, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Hailing Zhang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 215 Union Ave, Suite E, Bridgewater, NJ 08807 Phone: 908-685-0556 Fax: 908-685-0480 | |
Vinay Arya, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-253-3163 Fax: 908-704-1790 |